Dr. David A. Braun delved into the molecular factors which drive exceptional responses to immunotherapy in metastatic clear cell renal cell carcinoma.

Filmmaker Shaunak Sen reveals his early-stage renal cancer diagnosis and recovery journey Learn about kidney cancer symptoms ...

Renal cell carcinoma (RCC) refers to a heterogenous group of cancers that originate in the proximal convoluted tubule of the kidney. The three most common forms of RCC are clear cell RCC ...

Wade revealed Thursday that part of one of his kidneys were removed due to a tumor and that he underwent surgery in December ...

Management of advanced renal cell carcinoma remains a persistent clinical challenge with high morbidity and mortality for a large proportion of patients. Until recently, available medical ...

Discovery links cellular structures to kidney cancer treatment outcomes New research finds patterns in cells of tumors may guide personalized therapies for clear cell renal cell carcinoma Date ...

In the open-label phase 2 LITESPARK-003 study, led by Dana-Farber Cancer Institute's Toni Choueiri, MD, researchers ...

Dr. David A Braun delved into detail on the molecular factors driving exceptional responses to immunotherapy in metastatic ...

In the most common form of kidney cancer seen in adults—clear cell renal cell carcinoma, or "ccRCC," for short—the study found a correlation between the pattern of the speckles in the cancer ...

Patients with an anatomically or functionally solitary kidney, for example because of unilateral renal agenesis, previous contralateral nephrectomy or irreversible impairment of contralateral ...

KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.